Zhejiang Huakang Pharmaceutical Co., Ltd. (SHA:605077)

SHA:605077 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 28, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	4,980	4,384	4,385	5,077	6,931	6,829
Market Cap Growth	7.93%	-0.03%	-13.63%	-26.76%	1.50%	-
Enterprise Value	6,767	6,293	6,033	5,412	6,272	5,581
Last Close Price	16.79	14.78	14.07	15.42	21.17	20.43
PE Ratio	25.44	21.89	16.33	13.67	21.71	28.85
PS Ratio	1.19	1.05	1.56	1.82	3.15	4.28
PB Ratio	1.53	1.35	1.35	1.64	2.61	2.81
P/TBV Ratio	1.92	1.69	1.69	2.06	2.90	2.95
P/OCF Ratio	11.73	10.33	29.93	8.20	25.49	25.84
EV/Sales Ratio	1.62	1.50	2.15	1.95	2.85	3.50
EV/EBITDA Ratio	10.74	10.22	12.78	9.23	15.49	20.47
EV/EBIT Ratio	20.93	19.47	22.11	13.09	20.95	29.66
Debt / Equity Ratio	0.96	0.96	0.69	0.74	0.24	0.06
Debt / EBITDA Ratio	4.97	4.97	4.73	3.90	1.59	0.52
Net Debt / Equity Ratio	0.55	0.55	0.38	-0.10	-0.29	-0.48
Net Debt / EBITDA Ratio	2.88	2.88	2.59	-0.52	-1.93	-4.30
Net Debt / FCF Ratio	-30.05	-30.05	-0.95	4.25	2.92	12.13
Asset Turnover	0.56	0.56	0.43	0.55	0.64	0.72
Inventory Turnover	4.86	4.86	4.49	7.52	7.09	6.99
Quick Ratio	0.85	0.85	1.08	3.03	2.38	3.45
Current Ratio	1.40	1.40	1.54	3.34	2.78	3.96
Return on Equity (ROE)	6.23%	6.23%	8.46%	12.94%	12.54%	14.03%
Return on Assets (ROA)	2.69%	2.69%	2.59%	5.13%	5.42%	5.30%
Return on Invested Capital (ROIC)	5.72%	6.10%	7.03%	15.60%	17.78%	16.64%
Return on Capital Employed (ROCE)	5.80%	5.80%	5.10%	8.00%	9.50%	7.40%
Earnings Yield	4.02%	4.57%	6.12%	7.32%	4.61%	3.47%
FCF Yield	-1.18%	-1.34%	-29.26%	-1.40%	-3.86%	-1.42%
Dividend Yield	2.94%	-	3.55%	3.49%	2.18%	1.61%
Payout Ratio	126.54%	126.54%	73.21%	46.60%	35.06%	50.84%
Buyback Yield / Dilution	19.74%	19.74%	-27.25%	-0.23%	-3.09%	-28.98%
Total Shareholder Return	22.69%	19.74%	-23.70%	3.26%	-0.91%	-27.36%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.